Alex Fennell

Alex works within the life sciences field at Carpmaels & Ransford, with a particular focus on biotechnological inventions. He is involved in cases covering therapeutic antibodies, antisense compounds, microbiome compositions, gene therapies and biomedical methods. Alex is involved in the global prosecution of patent portfolios and has experience in EPO oppositions and appeals, as well as SPC prosecution. Alex has also worked on a number of high-profile cases before the UK High Court.

Alex graduated from Oxford University in 2010, having studied Molecular and Cellular Biochemistry. After his degree, Alex continued his research career and subsequently completed a Cancer Research UK funded PhD at University College London, the final year of which he spent at the National Institutes of Health in Bethesda, Maryland. During his PhD, Alex investigated the role of specialised chromosomal regions in regulating bipolar spindle formation in fission yeast. Alex’s work was published in a number of scientific journals and provided Alex with the opportunity to travel and present at international conferences.

After completion of his PhD in February 2015, Alex worked with Sir Paul Nurse at the Francis Crick Institute, researching the effect of environmental signals on cellular differentiation.

Alex entered the patent attorney profession in 2015 and is a qualified UK and European patent attorney. In 2017, Alex received a Distinction in the Certificate in Intellectual Property Law course at Queen Mary University of London.

In his spare time, Alex tries to keep fit by playing football and attending relentless circuit sessions. He is also a keen skier.